Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 6 | Retrovirology

Figure 6

From: Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity

Figure 6

Virus release from transfected cells and their infectivity. HeLa-tat III, 293T, and COS7 cells were transfected with mutant and wild type proviral DNAs as indicated. (A) Three days post-transfection, culture supernatants were collected and analyzed by CAp24-ELISA. (B) Normalized amounts of cleared and filtered culture supernatants from the above transfected cells were then used to infect MT4 cells (1 × 105 cells per well in 48-well plate) using 100 ng of CAp24 antigen. The bars indicate infectivity of the virus particles produced from the three different cell lines monitored by CAp24-ELISA.

Back to article page